Home » Novel Heart Disease Diagnostic Would Measure Risk by Testing the Gut
Novel Heart Disease Diagnostic Would Measure Risk by Testing the Gut
The saying that the way to a man’s heart is through the stomach might be true in more ways than one. Diagnostics company LipoScience is developing a new cardiovascular disease test that would use gut flora as a biomarker for cardiovascular risks.
MedCity News
MedCity News
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct